|
|
|
|
|
|
|
Proximagen announces positive efficacy results in NIH epilepsy studies | |
|
|
|
|
Compulsory Acquisition of Outstanding Minster Shares | |
|
|
|
|
Offer for Minster declared unconditional | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Recommended Cash Offer
Document | |
|
|
|
|
Posting of Offer Document | |
|
|
|
|
Recommended Cash Offer for Minster Pharmaceuticals Plc | |
|
|
|
|
Completion of Acquisition of Cambridge Biotechnology Ltd | |
|
|
|
|
Proximagen Acquires Cambridge Biotechnology Ltd | |
|
|
|
|
Letter of Intent to acquire Cambridge Biotechnology | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Result of General Meeting | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notice of Annual Report and Accounts | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Directors' Share Purchase | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Milestone and equity investment | |
|
|
|
|
Declaration of Major Shareholding | |
|
|
|
|
|
|
|
|
|
|
|
|
Declaration of Major Shareholding | |
|
|
|
|
Proximagen Signs $232 Million Licensing Agreement with Upsher-Smith | |
|
|
|
|
Proximagen 2008 AGM Proxy form | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change of Nomad and Broker | |
|
|
|
|
Director/PDMR Shareholding | |
|
|
|
|
|
|
|
|
Termination of Offer Period | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Disclosure of Information | |
|
|
|
| Notice of Interim Results | |
|
|
|
|
|
|
|
| Statement RE: Possible Offer | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Annual Report and AGM Date | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Annual Report and AGM Date | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Symposium and Pipeline Update | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
pdf